Liu Wenhao, Shan Jianyang, Zhu Mingming, Wen Gen, Cheng Liang
College of Fisheries and Life Science, Shanghai Ocean University, Shanghai, 201306, P. R. China.
Department of Orthopedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, P. R. China.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025 Mar 15;39(3):326-331. doi: 10.7507/1002-1892.202410054.
The self-defined multidisciplinary (endocrinology, vascular surgery, and orthopedics) scoring system (EMO scoring system for short) was designed. The feasibility of the EMO scoring system to guide the proximal tibial transverse transport (TTT) for diabetic foot wounds was preliminarily explored.
Based on the current commonly used clinical criteria for diabetic foot judgment, expert consensus, guidelines, and related research progress in the treatment of diabetic foot wounds, combined with clinical experience, a set of EMO scoring systems including endocrinology, vascular surgery, and orthopedics was formulated. The criteria for selecting conservative treatment, TTT after baseline improvement, and TTT based on scoring results was proposed. A total of 56 patients with diabetic foot wounds who were admitted between September 2017 and July 2022 and met the selection criteria was taken as the study subjects. Among them, 28 patients were treated with TTT and 28 patients were treated conservatively. The patients were graded according to the EMO scoring system, the corresponding treatment methods were selected, and the actual treatment methods and results of the patients were compared.
The EMO scoring system was formed through literature retrieval and clinical experiences. The system included three criteria, namely endocrinology (E), macrovascular disease (M), and orthopedics (O), which were divided into multiple subtypes according to the relevant evaluation items, and finally the diabetic foot wound was divided into 8 types, which correspondingly selected TTT, TTT after baseline improvement, and conservative treatment. All 56 patients were followed up 12 months after treatment. Among them, the wound healing rate of the TTT group was 85.71% (24/28), which was higher than that of the conservative treatment group [53.57% (15/28)]. At 12 week after treatment, CT angiography showed that there were more small blood vessels in the wound and ipsilateral limb in TTT group than in the conservative treatment group. Based on the EMO scoring system, 14 of the 56 patients needed conservative treatment, 29 patients needed TTT, and 13 patients needed TTT after baseline improvement. Compared with the clinical data of the patients, the wound healing rate of the patients judged to be TTT was 75.86% (22/29), of which 21 cases were actually treated with TTT, and the healing rate was 90.48%; 8 patients were treated conservatively, and the healing rate was 37.50%. The wound healing rate of the patients judged to be conservative treatment was 92.86% (13/14), of which 1 case was actually treated with TTT, and the healing rate was 100%; 13 cases were treated conservatively, and the healing rate was 92.31%; 1 case experienced minor amputation. The wound healing rate of the patients judged to TTT after baseline improvement was only 30.77% (4/13), of which 6 cases were actually treated with TTT, and the healing rate was 66.67%; 7 cases were treated conservatively, and the healing rate was 0.
EMO scoring system can comprehensively evaluate the diabetic foot wounds, and make personalized judgment on whether TTT treatment is feasible, so as to improve the level of diabetic foot wound treatment and the prognosis of patients.
设计了自定义的多学科(内分泌科、血管外科和骨科)评分系统(简称EMO评分系统)。初步探讨EMO评分系统指导糖尿病足伤口胫骨近端横向骨搬运(TTT)治疗的可行性。
基于目前常用的糖尿病足判断临床标准、专家共识、指南以及糖尿病足伤口治疗的相关研究进展,结合临床经验,制定了一套涵盖内分泌科、血管外科和骨科的EMO评分系统。提出了选择保守治疗、基线改善后进行TTT以及基于评分结果进行TTT的标准。选取2017年9月至2022年7月期间收治的56例符合入选标准的糖尿病足伤口患者作为研究对象。其中,28例行TTT治疗,28例行保守治疗。根据EMO评分系统对患者进行分级,选择相应的治疗方法,并比较患者的实际治疗方法和结果。
EMO评分系统通过文献检索和临床经验形成。该系统包括三个标准,即内分泌(E)、大血管疾病(M)和骨科(O),根据相关评估项目分为多个亚型,最终将糖尿病足伤口分为8种类型,分别对应选择TTT、基线改善后TTT和保守治疗。所有56例患者治疗后随访12个月。其中,TTT组伤口愈合率为85.71%(24/28),高于保守治疗组[53.57%(15/28)]。治疗12周后,CT血管造影显示TTT组伤口及同侧肢体的小血管较保守治疗组更多。基于EMO评分系统,56例患者中14例需要保守治疗,29例需要TTT,13例需要基线改善后TTT。与患者临床资料比较,判断为TTT的患者伤口愈合率为75.86%(22/29),其中21例实际行TTT治疗,愈合率为;8例保守治疗,愈合率为37.50%。判断为保守治疗的患者伤口愈合率为92.86%(13/14),其中)1例实际行TTT治疗,愈合率为;13例保守治疗,愈合率为92.31%;1例接受了小截肢手术。判断为基线改善后TTT的患者伤口愈合率仅为30.77%(4/13),其中6例实际行TTT治疗,愈合率为66.67%;7例保守治疗,愈合率为0。
EMO评分系统可综合评估糖尿病足伤口,对TTT治疗是否可行做出个性化判断,从而提高糖尿病足伤口治疗水平及患者预后。